Axela Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axela Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011834
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and applications support, on-site and in-house training, extended warranty, service and maintenance contracts; and custom application development services. The company creates tools and content to simplify multiplex biomarker detection for translational research and diagnostic testing. It markets its products through a network of distributors in Canada, Ireland, Belgium, Luxemburg, Spain, the Netherlands, the UK and the US. Axela is headquartered in Toronto, Ontario, Canada.

Axela Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axela Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axela Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axela Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axela Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axela Inc, Medical Devices Deals, 2011 to YTD 2017 9
Axela Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Axela Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
Asset Transactions 14
ANGLE Acquires Assets from Axela 14
Acquisition 15
Axela Mulls Offering Itself For Sale 15
Axela Inc – Key Competitors 16
Axela Inc – Key Employees 17
Axela Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Axela Inc, Pharmaceuticals & Healthcare, Key Facts 2
Axela Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axela Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axela Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axela Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Axela Inc, Medical Devices Deals, 2011 to YTD 2017 9
Axela Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
PAML Enters into Co-Development Agreement with Axela 11
Axela Enters Into Technology Integration Agreement With Thermal Gradient 12
Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker Analysis Platforms 13
ANGLE Acquires Assets from Axela 14
Axela Mulls Offering Itself For Sale 15
Axela Inc, Key Competitors 16
Axela Inc, Key Employees 17

★海外企業調査レポート[Axela Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Forent Energy Ltd. (FEN):企業概要、財務及び戦略的SWOT分析
    Summary Forent Energy Ltd (Forent) is an oil and natural gas producer. The company explores, develops and produces crude oil and natural gas reserves in western Canada and Nova Scotia. Its producing areas are located in Twining, Wayne and Provost in Southern Alberta. Forent’s areas of exploration ar …
  • Orascom Hotels and Development S.A.E.:企業の戦略・SWOT・財務分析
    SummaryOrascom Hotels and Development S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析
    Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • Theralase Technologies, Inc. (TLT):企業の財務及び戦略的SWOT分析
    Summary Theralase Technologies, Inc. (TTI) is a medical device company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products, which include controller, multiple probe, triple probe, single probe, multiple p …
  • Scatec Solar AS (SSO):企業のM&A・提携動向(エネルギー分野)
    Summary Scatec Solar AS (Scatec Solar) is an integrated independent solar power producing company. The company develops, builds, owns and operates solar power plants in the US, Czech Republic, South Africa, Jordan, Honduras, West Africa and Rwanda. It primarily involves in project development, finan …
  • American Airlines Group, Inc. (formerly AMR Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Airlines Group, Inc. ( …
  • Premier Oil Plc (PMO):企業の財務・戦略的SWOT分析
    Premier Oil Plc (PMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shibaura Electronics Co., Ltd. (6957):企業財務及び戦略的SWOT分析
    Summary Shibaura Electronics Co., Ltd. (Shibaura) is an electronic equipment company that develops and supplies thermistor elements and products utilizing thermistor elements. The company provides thermistors in the forms of elements and sensor assemblies. Its thermistor sensor products include auto …
  • GK Software AG (GKS):企業概要、財務及び戦略的SWOT分析
    Summary GK Software AG (GK Software) is a store solution provider. The company provides software solutions for the retail trade. Its products include product finder, SAP store solutions, GK-in-the-cloud, technology and standards, and internationalization. GK Software’s GK/retail suite offers market …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • University of Bristol-医療機器分野:企業M&A・提携分析
    Summary University of Bristol (UOB) is an educational service provider that offers undergraduate and postgraduate courses and research services. The university offers courses in arts, biomedical sciences, engineering, medical and veterinary sciences, dentistry, science, and social sciences and law. …
  • Fresenius Kidney Care:医療機器:M&Aディール及び事業提携情報
    Summary Fresenius Kidney Care (FMCNA), formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Northern Oil and Gas, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Northern Oil and Gas, Inc. Merg …
  • SH Energy & Chemical Co., Ltd. (002360):企業財務及び戦略的SWOT分析
    Summary SH Energy & Chemical Co., Ltd. (SH Energy) is a chemical company that produces and exports EPS resin products. The company products include anypol, anypol II, anybes, anyzon and shale gas. Its anypol expandable polystyrene resin is an expandable bead which includes a blowing agent, in specia …
  • American Builders & Contractors Supply Co Inc:企業の戦略・SWOT・財務情報
    American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report Summary American Builders & Contractors Supply Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • RLI Corp.:企業の戦略・SWOT・財務分析
    SummaryRLI Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …
  • Investigator Resources Limited (IVR):企業財務及び戦略的SWOT分析
    Summary Investigator Resources Limited (Investigator Resources), formerly Southern Uranium Limitedis a mineral exploration company that acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. The company’s projects include Peterlumbo JV, Paris Silver Pro …
  • Masimo Corporation (MASI):製品パイプライン分析2015
    Summary Masimo Corporation (Masimo) is a global medical technology company. It manufactures and distributes non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. Signal Extraction Technology (SET) is the company’s lead technology t …
  • Choppies Enterprises Limited (CHOPPIES):企業の財務・戦略的SWOT分析
    Choppies Enterprises Limited (CHOPPIES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆